Mammoth Diagnostics
Stage
Incubator/Accelerator | AliveAbout Mammoth Diagnostics
Mammoth's vision is to provide a CRISPR-based platform on which tests can be built by both the company and its partners. Through this platform, the company aims to provide access to a variety of tests for biosensing in healthcare, as well as across industries such as agriculture, manufacturing, forensics, and more.
- Predict emerging trends
- See competitors' playbooks
- Stalk the smart money
- Identify tomorrow's challengers
- Spot growing industries
- Kill analyst data work
Research containing Mammoth Diagnostics
Get data-driven expert analysis from the CB Insights Intelligence Unit.
CB Insights Intelligence Analysts have mentioned Mammoth Diagnostics in 2 CB Insights research briefs, most recently on Aug 31, 2021.
Aug 31, 2021
What Is CRISPR?
Jan 19, 2021
27 Corporate Innovation Labs In HealthcareMammoth Diagnostics Frequently Asked Questions (FAQ)
Where is Mammoth Diagnostics's headquarters?
Mammoth Diagnostics's headquarters is located at 953 Indiana St., San Francisco.
What is Mammoth Diagnostics's latest funding round?
Mammoth Diagnostics's latest funding round is Incubator/Accelerator.
Who are the investors of Mammoth Diagnostics?
Investors of Mammoth Diagnostics include JLabs.
- Predict emerging trends
- See competitors' playbooks
- Stalk the smart money
- Identify tomorrow's challengers
- Spot growing industries
- Kill analyst data work
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.
